Cell Sorter Market By Product (Instruments, Consumables and Reagents), By Application (Research Application, Clinical Applications), By End User (Hospitals and Clinical Testing Laboratories, Pharmaceutical and Biotechnology Companies, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
The cell sorter market was valued at $0.5 billion in 2022 and is estimated to reach $1.3 billion by 2032, exhibiting a CAGR of 8.6% from 2023 to 2032. Cell sorter is an instrument that is used for biological and medical research to isolate, analyze, and sort cells based on their physical and chemical properties. In addition, cell sorters are used in several applications such as immunology, cancer research, stem cell research, and microbiology. The cell sorter instruments use the principle of flow cytometry, which measure and analyze the characteristics of cells or particles. The cells are labeled with fluorescent markers that specifically bind to certain molecules or structures within the cells, allowing researchers to identify and quantify different cell types or subpopulation on the basis of their fluorescence signals.
The cell sorter market is driven by factors that include continuous technological advancements, such as improvements in sorting speed, increased sensitivity & accuracy, and the ability to handle a wide range of sample volumes. These advancements make cell sorters more efficient, user-friendly, and capable of handling diverse research requirements. In addition, the rise in incidence of chronic diseases, such as cancer, autoimmune disorders, and infectious diseases, creates a need for advanced research tools to understand disease mechanisms and develop effective treatments. Cell sorters facilitate in-depth cellular analysis, aiding in the discovery of novel therapeutic targets and diagnostic biomarkers, which support market growth.
The continuous advancements in cell biology research, such as studying rare cell population, understanding disease mechanisms, and exploring personalized medicine approaches, create a demand for cell sorting technologies and propels market growth. Cell sorters enable researchers to isolate specific cell types or subpopulation for further analysis and experimentation. Moreover, governments, private organizations, and funding agencies are increasingly investing in life sciences research, including cell biology and immunology. This funding supports the development and adoption of advanced research tools, including cell sorters, and drives market growth. However, the high cost of cell sorter instruments and lack of skilled professionals in developing countries limit the adoption of cell sorter and restrain market growth.
The cell sorter market is segmented into product, application, end user, and region. By product, the market is segregated into instruments and consumables & reagents. The instrument segment is further categorized into fluorescence-based droplet cell sorting, magnetic-activated cell sorting, and MEMS- Microfluidics. By application, the market is bifurcated into research applications and clinical applications. The research applications segment is further categorized into immunology & cancer research, stem cell research, drug discovery, and other research applications. By end user, the market is categorized into hospitals & clinical testing laboratories, pharmaceutical & biotechnology companies, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).
Major key players that operate in the cell sorter market are Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. Cytonome/St, LLC, Danaher Corporation, Harvard Bioscience, Inc., Miltenyi Biotec GmbH, On-Chip Biotechnologies Co., Ltd., Sony Corporation, Sysmex Corporation, and Thermo Fisher Scientific Inc. Key players have adopted product launch, partnership, and acquisition as key developmental strategies to improve the product portfolio of the cell sorter market.
Key Benefits For StakeholdersThis report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cell sorter market analysis from 2022 to 2032 to identify the prevailing cell sorter market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the cell sorter market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global cell sorter market trends, key players, market segments, application areas, and market growth strategies.
Key Market SegmentsBy ProductInstruments
Type
Fluorescence-based Droplet Cell Sorting
Magnetic-activated Cell Sorting
MEMS - Microfluidics
Consumables and Reagents
By ApplicationResearch Application
Type
Immunology and Cancer Research
Stem Cell Research
Drug Discovery
Other Research Applications
Clinical Applications
By End UserHospitals and Clinical Testing Laboratories
Pharmaceutical and Biotechnology Companies
Others
By RegionNorth America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Cytonome/St, LLC
Danaher Corporation
Harvard Bioscience, Inc.
Miltenyi Biotec GmbH
On-Chip Biotechnologies Co., Ltd.
Sony Corporation
Sysmex Corporation
Thermo Fisher Scientific Inc.
Please Note: It will take 7-10 business days to complete the report upon order confirmation.